TrialCancer science2021

First-line pembrolizumab vs chemotherapy in metastatic non-small-cell lung cancer: KEYNOTE-024 Japan subset.

Miyako Satouchi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.